We previously demonstrated that, in ex vivo cultures, IFN? downregulates the expression of MHC class II (MHCII) genes in human non-professional APCs associated with pancreatic islets. IFN? has an opposing effect on MHCII expression in professional APCs. In this study, we found that the mechanism responsible for the IFN?-mediated MHCII's downregulation in human MHCII-positive non-professional antigen presenting human non-hematopoietic cell lines is the result of the negative feedback system that regulates cytokine signal transduction, which eventually inhibits promoters III and IV of CIITA gene. Because the CIITA-PIV isoform is mostly responsible for the constitutive expression of MHCII genes in non-professional APCs, we pursued and achieved the specific knockdown of CIITA-PIV mRNA in our in vitro system, obtaining a partial silencing of MHCII molecules similar to that obtained by IFN?. We believe that our results offer a new understanding of the potential significance of CIITA-PIV as a therapeutic target for interventional strategies that can manage autoimmune disease and allograft rejection with little interference on the function of professional APCs of the immune system.
Contrasting effects of IFNalfa on MHC class II expression in professional vs. nonprofessional APCs: Role of CIITA type IV promoter
Pisapia L;Del Pozzo G;Barba P;Maffei A
2012
Abstract
We previously demonstrated that, in ex vivo cultures, IFN? downregulates the expression of MHC class II (MHCII) genes in human non-professional APCs associated with pancreatic islets. IFN? has an opposing effect on MHCII expression in professional APCs. In this study, we found that the mechanism responsible for the IFN?-mediated MHCII's downregulation in human MHCII-positive non-professional antigen presenting human non-hematopoietic cell lines is the result of the negative feedback system that regulates cytokine signal transduction, which eventually inhibits promoters III and IV of CIITA gene. Because the CIITA-PIV isoform is mostly responsible for the constitutive expression of MHCII genes in non-professional APCs, we pursued and achieved the specific knockdown of CIITA-PIV mRNA in our in vitro system, obtaining a partial silencing of MHCII molecules similar to that obtained by IFN?. We believe that our results offer a new understanding of the potential significance of CIITA-PIV as a therapeutic target for interventional strategies that can manage autoimmune disease and allograft rejection with little interference on the function of professional APCs of the immune system.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.